ICML 2019 | Recent publication on the impact of response to lymphodepletion on PFS in NHL

Alexandre Hirayama

Alexandre Hirayama, MD, Fred Hutchinson Cancer Research Center, Seattle, WA, discusses his recent research into the impact of response to lymphodepletion on PFS in non-Hodgkin lymphoma (NHL). This revealed that LDH, MCP-1, and IL-7 are independently associated with PFS in patients with aggressive NHL after CD19 CAR T-cell therapy. This interview took place at the 15th International Conference on Malignant Lymphoma (ICML), in Lugano, Switzerland.